Histochemical and functional evidence for a cholinergic innervation of the equine ureter.
The distribution of acetylcholinesterase (AChE)-positive nerve fibers and cells, as well as the effects of acetylcholine (ACh) on ureteral smooth muscle and small resistance arteries were investigated in the equine ureter by means of histochemical, classic organ baths and myograph techniques. AChE-positive nerve fibers were widely distributed throughout the ureteral wall forming muscular, subepithelial and perivascular nerve plexuses, whose density was highest at the intravesical ureter. AChE-positive nerve cells were also identified grouped as adventitial or intramural ganglia. ACh increased concentration-dependently both the frequency of phasic contractile activity and basal tone of the isolated intravesical ureter, the pD2 values being 6.31 +/- 0.18 and 6.59 +/- 0.13, respectively. The ACh-induced motor effects in ureteral smooth muscle were blocked by atropine, giving pIC50 values of 8.58 +/- 0.08 and 9.68 +/- 0.05 for phasic activity and tone, respectively. Hexamethonium only inhibited ACh-evoked contractile activity at the highest concentration used. ACh elicited a potent endothelium-dependent relaxation of equine ureteral resistance arteries precontracted with 40 mM K-PSS, the pD2 value being 7.94 +/- 0.07. This relaxant response was abolished in the presence of the nitric oxide (NO) inhibitor, NG-nitro-L-arginine (L-NNA), the blockade being reversed by subsequent incubation with the NO exogenous substrate, L-arginine. The ACh-induced relaxation was competitively antagonized by atropine (pA2 = 10.05 +/- 0.18). The present results suggest the existence of a rich cholinergic innervation in the equine ureter which controls both ureteral smooth muscle and resistance arteries motor activity through the muscarinic effects of ACh. In addition, the ACh relaxant response in the ureteral resistance arteries seems to be mediated by NO.
Prieto
D
D
Departamento de Fisiología, Facultad de Veterinaria, Universidad Complutense de Madrid, Spain.
Simonsen
U
U
Martín
J
J
Hernández
M
M
Rivera
L
L
Lema
L
L
García
P
P
García-Sacristán
A
A
D000109:Acetylcholine / Q000494:pharmacology; D000110:Acetylcholinesterase / Q000032:analysis; D000818:Animals; D001120:Arginine / Q000031:analogs & derivatives / Q000494:pharmacology; D001158:Arteries / Q000294:innervation; D001285:Atropine / Q000494:pharmacology; D015415:Biomarkers / Q000032:analysis; D002799:Cholinergic Fibers / Q000502:physiology / Q000648:ultrastructure*; D005260:Female; D018738:Hexamethonium; D006584:Hexamethonium Compounds / Q000494:pharmacology; D006736:Horses / Q000033:anatomy & histology*; D008297:Male; D009119:Muscle Contraction / Q000187:drug effects; D009130:Muscle, Smooth / Q000187:drug effects; D009419:Nerve Tissue Proteins / Q000032:analysis; D009569:Nitric Oxide / Q000502:physiology; D019335:Nitroarginine; D010528:Peristalsis / Q000502:physiology; D014513:Ureter / Q000098:blood supply / Q000294:innervation*
D015415:Biomarkers; D006584:Hexamethonium Compounds; D009419:Nerve Tissue Proteins; D019335:Nitroarginine; D009569:Nitric Oxide; D018738:Hexamethonium; D001285:Atropine; D001120:Arginine; D000110:Acetylcholinesterase; D000109:Acetylcholine